Astrazeneca Pharma India Ltd share price logo

Astrazeneca Pharma Share Price

NSE: ASTRAZEN

BSE: 506820

Small Cap

Healthcare Sector

₹7931.00

-484.00

(-5.75%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Astrazeneca Pharma Stock Performance

as on March 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹7,806.50
    ₹8,442.00
    downward going graph

    1.57%

    Downside

    6.44%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹7,201.15
    ₹10,691.00
    downward going graph

    9.20%

    Downside

    34.80%

    Upside

    downward going graph

Astrazeneca Pharma share price movements today

Previous Close
₹8,415.00
Open
₹8,400.50
Volume
62.98K
Upper Circuit
₹10,098.00
Lower Circuit
₹6,732.00
Day's Low - High
₹7,806.50 - ₹8,442.00
52 Week Low - High
₹7,201.15 - ₹10,691.00

Astrazeneca Pharma Historical Returns

1 Month Return
-9.89 %
3 Month Return
-12.3 %
1 Year Return
-7.86 %
3 Year Return
+ 136.96 %
5 Year Return
+ 160.83 %

Astrazeneca Pharma Fundamentals

as on March 27, 2026 at 4:01 pm IST

Market Cap

₹19,827.50 Cr

Return on Equity (ROE)

23.63

PE Ratio (TTM)

0

Return on capital employed (ROCE)

32.94

Beta (LTM)

0.51

P/B Ratio

27.93

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

5.64

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Astrazeneca Pharma India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Astrazeneca Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA19,827.5032.17%0.001151,716
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY11,580.31-7.38%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY13,448.903.92%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY3,923.14-3.31%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY11,825.5531.73%0.672441,515
See all

Astrazeneca Pharma Stock’s Investor Sentiment and Interest

Search interest for Astrazeneca Pharma India Ltd Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Astrazeneca Pharma India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
284.7
295.47
311.07
305.79
383.2
387.52
408
440.29
480.48
526.31
559.09
611.57
Other Income
8
8.1
24.8
9.66
8.66
8.35
8.15
7.98
16.15
11.24
6.17
6.61
Total Income
292.7
303.57
335.87
315.45
391.86
395.87
416.15
448.27
496.63
537.55
565.26
618.18
Expenses
265.08
228.23
258.31
290.74
333.81
407.01
355.46
396.85
399.79
445.56
489.2
566.74
Operating Profit
19.62
67.24
52.76
15.05
49.39
-19.49
52.54
43.44
80.69
80.75
69.89
44.83
Operating Profit Margin %
6.89%
22.76%
16.96%
4.92%
12.89%
-5.03%
12.88%
9.87%
16.79%
15.34%
12.5%
7.33%
Profit Before Interest, Tax and Depreciation
27.62
75.34
77.56
24.71
58.05
-11.14
60.69
51.42
96.84
91.99
76.06
51.44
Interest
0.09
0.15
0.5
0.61
-0.07
0.11
0.34
0.33
0.68
0.72
0.67
1.06
Depreciation
4.25
3.79
3.68
3.7
3.76
3.91
9.32
9.07
17.69
16.57
2.57
3.84
Profit Before Tax
23.28
71.4
73.38
20.4
54.36
-15.16
51.03
42.02
78.47
74.7
72.82
46.54
Tax Paid
6.01
17.54
21.01
4.6
14.88
-3.37
12.6
11.17
20.22
18.87
18.6
13.95
Profit After Tax
17.27
53.86
52.37
15.8
39.48
-11.79
38.43
30.85
58.25
55.83
54.22
32.59
Total Net profit including share of profit / Loss from associate company
17.27
53.86
52.37
15.8
39.48
-11.79
38.43
30.85
58.25
55.83
54.22
32.59
EPS
6.91
21.54
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
Actual EPS
6.91
21.54
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
Adjusted EPS
6.91
21.54
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
Diluted EPS
6.91
21.54
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04

Astrazeneca Pharma India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
543.7
571
728.29
831.81
813.56
805.6
1,002.97
1,295.53
1,716.29
Other Income
14.39
12.25
16.29
12.99
12.84
14.76
26.1
51.23
40.63
Total Income
558.09
583.25
744.58
844.8
826.41
820.36
1,029.07
1,346.76
1,756.92
Expenses
506.76
524.71
656.99
711.11
678.09
719.43
878.07
1,111.08
1,559.11
Operating Profit
36.94
46.29
71.3
120.7
135.47
86.17
124.9
184.45
157.18
Operating Profit Margin %
6.79%
8.11%
9.79%
14.51%
16.65%
10.7%
12.45%
14.24%
9.16%
Profit Before Interest, Tax and Depreciation
51.33
58.54
87.59
133.69
148.31
100.93
151
235.68
197.81
Interest
-
-
-
1.14
1.09
0.95
0.63
1.2
1.46
Depreciation
15.83
14.74
14.92
18.58
20.13
16.95
16.26
14.94
39.99
Profit Before Tax
35.5
43.8
72.67
113.97
127.09
83.03
134.11
219.54
156.36
Tax Paid
15.45
17.89
18.22
41.75
33.79
21.44
34.81
58.03
40.62
Profit After Tax
20.05
25.91
54.44
72.22
93.3
61.59
99.29
161.51
115.74
Total Net profit including share of profit / Loss from associate company
20.05
25.91
54.44
72.22
93.3
61.59
99.29
161.51
115.74
EPS
8.02
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
Actual EPS
8.02
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
Adjusted EPS
8.02
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
Diluted EPS
8.02
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3

Astrazeneca Pharma India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
56.99
38.1
8.79
54.98
87.42
104.78
100.8
58.29
27.87
65.36
Cash Flow from Investing Activities
-3.6
0.25
-9.36
4.28
-170.8
173.03
4.74
18.11
21.74
30.8
Cash Flow from Financing Activities
-0.22
-
-
-
-6.36
-8.97
-9.46
-24.48
-44.38
-65.59
Net Cash Flow
52.87
38.35
-0.57
59.26
-89.74
268.84
96.08
51.92
5.23
30.57

Astrazeneca Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
75%
75%
75%
75%
75%
75%
75%
75%
75%
75%
75%
DII
1.93%
2.43%
2.75%
3.78%
5.01%
5.1%
5.22%
4.65%
4.56%
5.26%
5.56%
FII
0%
2.69%
0%
2.74%
2.79%
2.9%
2.93%
2.89%
3.03%
2.74%
2.71%
Public
20.4%
19.88%
19.57%
18.48%
17.2%
17%
16.85%
17.46%
17.41%
17%
16.73%
Total Outstanding Shares
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
Total Shareholders
38,946
32,380
29,032
29,418
27,169
27,615
27,322
32,466
34,378
32,914
31,551

Mutual Funds that own Astrazeneca Pharma Stock

Check out the Mutual Funds with significant holdings in Astrazeneca Pharma.

Astrazeneca Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Astrazeneca Pharma.

  • Astrazeneca Pharma India Ltd Earnings Results

    Astrazeneca Pharma India Ltd’s net profit jumped 5.64% since last year same period to ₹32.59Cr in the Q3 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -39.89% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Astrazeneca Pharma India Ltd Dividends May,2025

    In the quarter ending March 2025, Astrazeneca Pharma India Ltd has declared dividend of ₹32.00 per share on 30 May 2025 - translating a dividend yield of 0.40%.

    Read More about Dividends

Indices Featuring Astrazeneca Pharma Stock

Check stock indices that include Astrazeneca Pharma.

S&P BSE 400 MidSmallCap

₹10,738.13

-2.06 (▲226.12%)

Nifty Smallcap 250

₹14,655.35

-1.89 (▲281.85%)

Nifty 500

₹21,020.15

-2.13 (▲458.05%)

BSE Healthcare

₹42,427.96

-0.73 (▲311.37%)

S&P BSE 250 SmallCap

₹5,795.67

-1.82 (▲107.32%)

BSE 500

₹32,935.19

-2.11 (▲710.70%)

Nifty MidSmallcap 400

₹17,988.25

-2.08 (▲382.50%)

Insights on Astrazeneca Pharma India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, ASTRAZEN stock has moved up by 137.0%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.00% to 5.43% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.2% return, outperforming this stock by 40.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 75.00% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 262.3% return, outperforming this stock by 125.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.74% to 2.71% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.00% to 16.73% in Dec 2025 quarter

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on the 11th of July 1979 and is a subsidiary of AstraZeneca Pharmaceuticals AB Sweden, which is an indirect subsidiary of AstraZeneca Plc. It is engaged in manufacture, distribution and marketing of pharmaceutical products in therapy areas such as Onocology, Alimentary Metabolism, Cardio Vascular, Renal Diabetes, Respiratory and Oncology. The company suffered a performance setback due to supply stabilization in 2012, following which the current year witnessed series of regulatory interventions in the Indian Pharmaceutical Market covering 348 medicines including 15 SKUs across 8 brands of the company listed on the National List of Essential Medicines (NLEM). During the year, APIL introduced Arimidex, an Oncology product for the management of breast cancer and decided to make its Astrazeneca India’s RD as a part of its global RD organisation. In 2013-14, the market share of drug brand Brilinta (Ticagrelor) which provides cardiologists with a new and effective treatment to help reduce the rate of heart attack and cardiovascular deaths grew from 1.4 MAT March 2013 to 6.7 MAT March 2014. For the FY 2013-14, the company experienced a range of patient price reduction of 452 and an average price reduction of 30. In 2015-16, key growth brands of APIL such as Brilinta, Forxiga, Onglyza, Kombiglyze, Symbicort witnessed robust growth and diabetes portfolio grew by 74 post acquisition from Bristol MyersSquibb. Meanwhile, Meronem became the company’s first brand to cross the Rs. 100 crore sales milestone. The company entered into three Distribution Services Agreements with Dr. Reddy's Laboratories, Sun Pharma for Ticagrelor and Diabetes treatments, while APIL, Dr. Reddy's Laboratories and Sun Pharma copromote market and distributed Saxagliptin, Dapagliflozin and Ticagrelor under different brand names in Indian markets. During 2017-18, the company aligned its portfolio to AstraZeneca's Global therapeutic focus and introduced Xigduo, a fixed dose combination drug to improve glycemic control for type 2 diabetes mellitus. In 2020-21, the company launched Lynparza, Calquence Acalabrutinib and Benralizumab

Revenue: ₹611.57Cr as on December 2025 (Q3 FY26)
Net Profit: ₹32.59Cr as on December 2025 (Q3 FY26)
Listing date: 30 Jul, 1998
Chairperson Name: Narayan K Seshadri
OrganisationAstrazeneca Pharma India Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEONarayan K Seshadri
E-voting on sharesClick here to vote

FAQs

What is Astrazeneca Pharma share price today?

Astrazeneca Pharma share price today stands at ₹7931 as on at the close of the market. Astrazeneca Pharma share today touched a day high of ₹8442 and a low of ₹7806.5.

What is the 52 week high and 52 week low range for Astrazeneca Pharma share?

Astrazeneca Pharma touched a 52 week high of ₹10691 and a 52 week low of ₹7201.15. Astrazeneca Pharma share price today i.e. is closed at ₹7931, which is -25.82% down from its 52 week high and 10.14% up from its 52 week low.

What is Astrazeneca Pharma's market capitalisation today?

Astrazeneca Pharma market capitalisation is ₹19,827.50 Cr as on .

How to buy Astrazeneca Pharma shares?

To buy Astrazeneca Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ASTRAZEN or Astrazeneca Pharma India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Astrazeneca Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Astrazeneca Pharma trading volume today?

Astrazeneca Pharma trading volume is 62.98K as on . This means that 62.98K shares of Astrazeneca Pharma were bought and sold on the stock market during today's trading session.